VRC-HIVMAB0107-00-AB
- Generic Name
- VRC-HIVMAB0107-00-AB
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-01-30
- Target Recruit Count
- 48
- Registration Number
- NCT06517693
- Locations
- π΅π·
Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research, San Juan, Puerto Rico
πΊπΈSite 5030, Emory University School of Medicine, Atlanta, Georgia, United States
πΊπΈSite 5112, David Geffen School of Medicine at UCLA, Los Angeles, California, United States
The Tatelo Plus Study
- Conditions
- HIVHIV Infections
- Interventions
- Other: Analytic Treatment InterruptionDrug: ART Regimen prior to enrolling in Step 1aDrug: ART Regimen prior to enrolling in Step 1b
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 41
- Registration Number
- NCT06508749
- Locations
- π§πΌ
Francistown CRS (CRS #31891), Francistown, Botswana
π§πΌBotswana Harvard Health Partnership CRS (CRS #31833), Gaborone, Botswana
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
- Conditions
- Acute HIV Infection
- Interventions
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2025-04-23
- Target Recruit Count
- 48
- Registration Number
- NCT05719441
- Locations
- πΊπΈ
31788, Alabama CRS, Birmingham, Alabama, United States
πΊπΈ1201, University of Southern California CRS, Los Angeles, California, United States
πΊπΈ601, University of California, Los Angeles CARE Center CRS, Los Angeles, California, United States
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2024-12-13
- Target Recruit Count
- 33
- Registration Number
- NCT04212091
- Locations
- πΊπΈ
George Washington Univ. CRS, Washington, District of Columbia, United States
πΊπΈColumbia P&S CRS, New York, New York, United States
πΊπΈThe Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.